2m 2m 2m 2m 2m 2m 2m
Cryomass Tech (CRYM)
OTC
$0.000001$0.00 (0.00%)
Price as of May 29, 2026- $237.00Market Cap
- -100.00%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Cryomass Tech (CRYM)
$0.000001$0.00 (0.00%)
Annual
Quarterly
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 13,552 N/A | N/A N/A | 5.9M +653.96% | 781,455 N/A | |
Cost of Revenue | N/A N/A | N/A N/A | 4.1M +455.26% | 744,279 N/A | |
Gross Profit | 13,552 N/A | 0 -100.00% | 1.8M +4,632.08% | 37,176 N/A | |
Sales and Marketing Expense | N/A N/A | N/A N/A | 44,095 +196.86% | 14,854 N/A | |
Research and Development Expense | -13,361 -34.88% | -20,518 -99.36% | -3.2M N/A | N/A N/A | |
Depreciation and Amortization Expense | 329,223 +109.69% | 157,001 +259.57% | 43,663 +62.31% | 26,901 N/A | |
Total Operating Expenses | 10.8M +4.69% | 10.3M +29.03% | 8.0M +21.60% | 6.6M N/A | |
Operating Profit | -10.8M +4.56% | -10.3M +29.03% | -8.0M +22.30% | -6.5M N/A | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -388,909 +164.54% | -147,014 +195.19% | -49,803 -67.57% | -153,592 N/A | |
Interest Income and Expense and Net | -388,909 +164.54% | -147,014 +195.19% | -49,803 -67.57% | -153,592 N/A | |
Total Nonoperating Income and Expense | -2.2M +1,521.96% | -132,669 -93.81% | -2.1M +558.11% | -325,602 N/A | |
Income before Taxes | -12.9M +23.84% | -10.4M +3.06% | -10.1M +47.73% | -6.9M N/A | |
Income Taxes | 21,788 +200.00% | -21,788 +112.88% | -10,235 -200.00% | 10,235 N/A | |
Extraordinary Items | 1.2M N/A | N/A N/A | 4.7M +1,191.05% | 361,218 N/A | |
Net Income | -13.0M +24.30% | -10.4M -18.95% | -12.9M +8.83% | -11.8M N/A | |
Net Income from Continuing Operations Applicable to Common | -12.9M +23.84% | -10.4M +3.06% | -10.1M +47.73% | -6.9M N/A | |
Basic EPS and Net Income | -0.06 +20.00% | -0.05 N/A | N/A N/A | -0.12 N/A | |
Diluted EPS and Net Income | -0.06 +20.00% | -0.05 -16.67% | -0.06 -50.00% | -0.12 N/A | |
Basic Weighted Average Shares | 206.8M +2.95% | 200.9M +27.54% | 157.5M +57.73% | 99.9M N/A | |
Diluted Weighted Average Shares | 206.8M +2.95% | 200.9M +27.54% | 157.5M +57.73% | 99.9M N/A | |
Balance Sheet | |||||
Cash and Cash Equivalents | 49,224 -97.56% | 2.0M -65.08% | 5.8M +1,650.20% | 329,839 N/A | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 49,224 -97.56% | 2.0M -65.08% | 5.8M +1,650.20% | 329,839 N/A | |
Total Current Assets | 152,522 -92.96% | 2.2M -66.82% | 6.5M -16.26% | 7.8M N/A | |
Accumulated Depreciation | 54,761 +914.09% | 5,400 N/A | N/A N/A | 1.4M N/A | |
Property and Plant and Equipment and Net | 723,072 +37.50% | 525,855 +133.71% | 225,000 -91.71% | 2.7M N/A | |
Total Long-Term Assets | 723,072 +37.50% | 525,855 +133.71% | 225,000 -91.71% | 2.7M N/A | |
Total Assets | 972,506 -87.63% | 7.9M -49.54% | 15.6M +99.84% | 7.8M N/A | |
Income Taxes Payable | 38,048 N/A | N/A N/A | 771 -95.09% | 15,697 N/A | |
Total Short-Term Debt | 237,500 N/A | N/A N/A | N/A N/A | 412,560 N/A | |
Total Current Liabilities | 2.5M +93.56% | 1.3M -31.55% | 1.9M -54.38% | 4.1M N/A | |
Total Long-Term Debt | 3.1M +53.39% | 2.0M +1,029.41% | 177,083 +240.00% | 52,083 N/A | |
Total Long-Term Liabilities | 2.5M +27.27% | 2.0M +1,029.41% | 177,083 +493.20% | 29,852 N/A | |
Total Liabilities | 6.8M +107.44% | 3.3M +59.67% | 2.1M -50.88% | 4.2M N/A | |
Retained Earnings | -52.0M +33.21% | -39.0M +36.46% | -28.6M +81.76% | -15.7M N/A | |
Total Stockholders Equity | -5.8M -227.87% | 4.6M -66.18% | 13.5M +275.12% | 3.6M N/A | |
Total Shares Outstanding | 210.0M +3.64% | 202.7M +2.89% | 196.9M +103.03% | 97.0M N/A | |
Cash Flow | |||||
Cash from Operating Activities | -3.8M -20.18% | -4.8M -14.89% | -5.6M +49.36% | -3.7M N/A | |
Capital Expenditures | 25,000 -91.69% | 300,855 +33.71% | 225,000 N/A | N/A N/A | |
Cash from Investing Activities | -74,236 -92.71% | -1.0M -63.66% | -2.8M +304.36% | -693,255 N/A | |
Dividends Paid | N/A N/A | N/A N/A | 10.5M N/A | N/A N/A | |
Cash from Financing Activities | 1.9M -5.74% | 2.0M -85.35% | 13.8M +966.00% | 1.3M N/A | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | 29.86% +527.62% | 4.76% N/A | |
Operating Margin | -79,560.93% N/A | N/A N/A | -135.64% -83.78% | -836.24% N/A | |
Return on Assets | -293.27% +229.87% | -88.91% -19.17% | -110.00% +11.10% | -99.01% N/A | |
Return on Equity | 2,032.63% +1,864.81% | -115.18% -23.29% | -150.15% +1.94% | -147.29% N/A | |
Revenue Growth | N/A N/A | N/A N/A | 653.96% +943.43% | -77.54% N/A | |
Current Ratio | 0.06 -96.36% | 1.68 -51.53% | 3.47 +83.54% | 1.89 N/A | |
Cash Ratio | 0.02 -98.74% | 1.56 -48.98% | 3.07 +3,738.17% | 0.08 N/A | |
Debt-to-Equity Ratio | -0.57 N/A | N/A N/A | N/A N/A | 0.13 N/A | |
Debt-to-Assets Ratio | 3.40 N/A | N/A N/A | N/A N/A | 0.06 N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow